[Featured Stock] Green Cross MS Surges 25.8% Amid COVID-19 Increase
Green Cross MS is showing strong performance.
As of 10:04 AM on the 16th, Green Cross MS is trading at 6,390 KRW on the KOSDAQ market, up 1,310 KRW (25.79%) from the previous trading day.
It is interpreted that the recent sharp increase in the number of patients hospitalized due to COVID-19 is influencing the stock price.
Hot Picks Today
Wealth Surpasses 20 Quadrillion Won... The Super-Rich Score Big, But Where Did the Money Flow?
- Trusted the 'Helper' and Opened the Door... She Returned and Stole Nearly 60 Million Won
- "Even as Stocks Tumble, I Trusted You"... The Secret of the ETF with Steady Upward Momentum [Weekend Money] [Weekend Money]
- "Kkokkalcorn Placed Next to Pork Belly Causes a Sensation... Sells Out Three Months’ Stock at Five Times the Usual Speed"
- "Just Drinking to Lift Your Mood"...Unexpected Warning: Raises Risk of Cancer Death
Green Cross MS was established in 2003 with the business purpose of manufacturing and selling in vitro diagnostic pharmaceuticals and medical devices, as well as manufacturing and selling pharmaceuticals and quasi-drugs.
![[Featured Stock] Green Cross MS Surges 25.8% Amid COVID-19 Increase](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
The company is composed of three business divisions: diagnostic reagents, hemodialysis solutions, and diabetes. By handling products in various fields together, it supplies to a wide range of customers including public health centers, screening centers, internal medicine clinics, dermatology clinics, plastic surgery clinics, hospitals, general hospitals, and university hospitals, thereby maintaining an extensive domestic sales network.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
